Clinical Trials
26 trialsCHECK
Mario Negri Institute for Pharmacological Research
HIPECT4
Maimónides Biomedical Research Institute of Córdoba
BCG+MM
University of Sydney
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
University of Kansas Medical Center
BL-PDT-RCT
First Affiliated Hospital Xi'an Jiaotong University
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
CALIBER
Institute of Cancer Research, United Kingdom
MITOBCG
Azienda Ospedaliera "Sant'Andrea"
Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
ChineseAMS
HYCAN
University of Erlangen-Nürnberg Medical School
CORTT
Sun Yat-sen University
Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma
Second Military Medical University
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
National Cancer Institute (NCI)
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
National Cancer Institute (NCI)
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
National Cancer Institute (NCI)
Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor
Copenhagen University Hospital at Herlev
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
Croatian Cooperative Group for Clinical Research in Oncology
IPHC
Wuhan University
Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Shenzhen Kangzhe Pharmaceutical Co., Ltd.